Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun;51(6):1724-31.
doi: 10.1016/j.eururo.2006.11.026. Epub 2006 Nov 16.

Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms

Heather Valentine  1 , Yi Chen, Hongzhi Guo, Jocelyn McCormick, Yong Wu, Sena F Sezen, Ahmet Hoke, Arthur L Burnett, Joseph P Steiner
Affiliations

Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms

Heather Valentine et al. Eur Urol. 2007 Jun.

Abstract

Objectives: We investigated the effects of the orally bioavailable non-immunosuppressive immunophilin ligand GPI 1046 (GPI) on erectile function and cavernous nerve (CN) histology following unilateral or bilateral crush injury (UCI, BCI, respectively) of the CNs.

Methods: Adult male Sprague-Dawley rats were administered GPI 15 mg/kg intraperitoneally (ip) or 30 mg/kg orally (po), FK506 1 mg/kg, ip, or vehicle controls for each route of administration just prior to UCI or BCI and daily up to 7 d following injury. At day 1 or 7 of treatment, erectile function induced by CN electrical stimulation was measured, and electron microscopic analysis of the injured CN was performed.

Results: Intraperitoneal administration of GPI to rats with injured CN protected erectile function, in a fashion similar to the prototypic immunophilin ligand FK506, compared with vehicle-treated animals (93%+/-9% vs. 70%+/-5% vs. 45%+/-1%, p<0.01, respectively). Oral administration of GPI elicited the same level of significant protection from CN injury. GPI administered po at 30 mg/kg/d, dosing either once daily or four times daily with 7.5 mg/kg, provided nearly complete protection of erectile function. In a more severe BCI model, po administration of GPI maintained erectile function at 24 h after CN injury. Ultrastructural analysis of injured CNs indicated that GPI administered at the time of CN injury prevents degeneration of about 83% of the unmyelinated axons at 7 d after CN injury.

Conclusions: The orally administered immunophilin ligand GPI neuroprotects CNs and maintains erectile function in rats under various conditions of CN crush injury.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ICP is maintained in UCI following intraperitoneal treatment of GPI. The right CN was crushed as described in methods. Both vehicle and GPI (15 mg/kg, ip) treatment preceded the nerve crush by 30 min. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). (A). The ICP responses were recorded as a function of time and depicted for both the GPI-treated (left panel) and the vehicle-treated (right panel) rats. (B). Comparison of the maximum ICP response data from graphs in A. Statistical difference defined as * p < 0.01, n = 6 per group. CN = cavernous nerve; GPI = GPI-1046; ICP = intracavernosal pressure; ip = intraperitoneal; UCI = unilateral crush injury.
Fig. 2
Fig. 2
Intraperitoneal administration of FK506 and GPI maintains ICP responses in rats with UCI. Rats were treated with vehicle, GPI (15 mg/kg), or FK506 (1 mg/kg) for 30 min prior to UCI. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). The ICP response was expressed as %ICP of the uninjured CN stimulation for UCI. Statistical difference defined as * p < 0.05, ** p < 0.01, n = 6 per group. See Figure 1 for definitions of abbreviations.
Fig. 3
Fig. 3
Oral administration of GPI maintains ICP responses in rats with UCI. Both the vehicle and GPI (30 mg/kg) treatment preceded the nerve crush by 30 min. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). Data were expressed as mean ± SE of maximum ICP. Statistical difference defined as * p < 0.05, n = 8 per group. See Figure 1 for definitions of abbreviations.
Fig. 4
Fig. 4
Oral administration of GPI maintains ICP responses in rats 7 d after UCI. Rats were treated for 7 d with vehicle or GPI starting 30 min prior to UCI. (A) Vehicle or GPI (30 mg/kg/d). (B) Vehicle or GPI (7.5 mg/kg, po). Seven days after UCI, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). The ICP response was expressed as %ICP of the uninjured CN stimulation. Statistical difference defined as ** p < 0.01, n = 8/group. See Figure 1 for definitions of abbreviations.
Fig. 5
Fig. 5
Oral administration of GPI maintains ICP responses in rats with BCI. Rats were administered vehicle or GPI (30 mg/kg) 30 min prior to BCI. A group of sham rats were run in parallel for comparison. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). Data was expressed as mean ± SE of maximum ICP. Statistical difference defined as ** p < 0.001, n = 8 per group. BCI = bilateral crush injury; see Figure 1 for definitions of other abbreviations.
Fig. 6
Fig. 6
GPI treatment prevents degeneration of unmyelinated axons in the distal CN. Rats with UCI were treated with vehicle or GPI (15 mg/kg, ip), and the CNs were evaluated for axonal degeneration by EM (see Methods). (A) Quantitation of the right CN (crush) unmyelinated axon survival at 7 d after injury in vehicle- or GPI- treated animals (N = 4 per group, p = 0.007). Representative EMs of (B) left CN (control); (C) right CN (crush) with GPI treatment; (D) right CN (crush) with vehicle treatment. There are more degenerating unmyelinated axons in the vehicle-treated nerves (narrow arrows point to some of the degenerating axons; thick arrow points to a degenerating small myelinated axon). EM = electron microscopy; see Figure 1 for definitions of other abbreviations.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA. 2005;293:2648–53. - PubMed
    1. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med. 2005;2:658–67. - PubMed
    1. Carrier S, Zvara P, Nunes L, et al. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol. 1995;153:1722–7. - PubMed
    1. Bochinski D, Lin GT, Nunes L, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004;94:904–9. - PubMed
    1. Chen KC, Minor TX, Rahman NU, et al. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence. BJU Int. 2005;95:1077–80. - PubMed

Publication types